https://www.selleckchem.com/pr....oducts/pf-07220060.h
To achieve the elimination of hepatitis B and C, there is an urgent need to develop alternative strategies to increase the access of diagnosis, particularly among key populations such as people living with human immunodeficiency virus (HIV), individuals with coagulopathies and chronic kidney disease (CKD) patients. To evaluate the use of dried blood spot (DBS) in the detection of hepatitis B virus (HBV) and hepatitis C virus (HCV) markers. A total of 430 individuals comprised of people living with HIV, coagulopathies and CKD provide
Like
Comment
Share
